·
4 Min Read

AMA adopts new policies on substance use during second day of Annual Meeting

Policies address opioid crisis and medicinal use of psychedelics.

Press Releases
AMA in Action: Ending the overdose epidemic
UPDATED
·
4 Min Read

Advocacy in action: Ending the overdose epidemic

Science, evidence and compassion must guide patient care and policy change to end the drug-overdose epidemic.

Behavioral Health
Narcan nasal spray
·
4 Min Read

Narcan lands OTC approval: What it means for patients, doctors

The drug’s manufacturer and retailers must help ensure the lifesaving opioid overdose-reversal medication is widely available at an affordable price. 

Behavioral Health
·
11 Min Read

Naloxone: FDA approves over-the-counter Narcan nasal spray with Bobby Mukkamala, MD

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about Narcan, the over-the-counter naloxone nasal spray, and more.

series
Behavioral Health
AMA Update
·
11 Min Read

Naloxone: FDA approves over-the-counter Narcan nasal spray with Bobby Mukkamala, MD [Podcast]

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about Narcan, the over-the-counter naloxone nasal spray, and more.

series
Behavioral Health
AMA Update Podcast
Katherine Pannel, DO
·
6 Min Read

How this DO’s advocacy will help prevent drug-overdose deaths

AMA member Katherine Pannel, DO, helped persuade lawmakers to decriminalize fentanyl test strips in Mississippi. Learn more.

Behavioral Health
·
3 Min Read

AMA launches resource to help physicians meet DEA training requirement

The AMA Ed Hub™ has a new educational webpage for physicians to complete required training on treating patients with opioid or other substance use disorders.

Press Releases
·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of March 27, 2023

In the news: FDA rule on salt substitutes, undiagnosed atrial fibrillation in the U.S., Narcan (naloxone) to be available over the counter and more.

Publications & Newsletters
Rahul Gupta, MD, speaking at the 2023 National Advocacy Conference
·
5 Min Read

Every 5 minutes a person dies of drug overdose. This must end.

Rahul Gupta, MD, MPH, is the first physician to direct the White House’s drug-control policy. Learn why he says treatment is key to the strategy.

Behavioral Health